Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cooper Co ( (COO) ) has issued an announcement.
On December 22, 2025, CooperCompanies entered into a cooperation agreement with investment firm Browning West, under which the company appointed veteran medical device executive Walter M. Rosebrough Jr. to its board and its Corporate Governance and Nominating Committee, effective January 3, 2026. The deal commits Cooper to supporting Rosebrough’s election at the 2026 annual meeting, conducting a Browning West–approved search for an additional independent director with medical technology experience by June 30, 2026, capping the board at ten members during the agreement term, and giving due consideration to naming Rosebrough board chair by the end of 2026, while Browning West agrees to standstill and voting commitments, including backing the company’s full slate in 2026. The move, announced in a December 23, 2025 press release, effectively aligns Cooper with an influential shareholder, brings in a director with a strong track record of value creation in the medical device sector, and signals further board refreshment aimed at strengthening governance and supporting long-term shareholder value.
The most recent analyst rating on (COO) stock is a Hold with a $88.00 price target. To see the full list of analyst forecasts on Cooper Co stock, see the COO Stock Forecast page.
Spark’s Take on COO Stock
According to Spark, TipRanks’ AI Analyst, COO is a Outperform.
Cooper Co’s overall stock score is driven by strong technical indicators and solid financial performance, despite valuation concerns. The company’s strategic initiatives and growth prospects, particularly in CooperVision, are positive, but challenges in certain markets and high valuation metrics temper the score.
To see Spark’s full report on COO stock, click here.
More about Cooper Co
CooperCompanies (Nasdaq: COO) is a leading global medical device company operating through two business units: CooperVision, a major player in the contact lens industry, and CooperSurgical, which focuses on fertility and women’s healthcare. Headquartered in San Ramon, California, the company employs more than 15,000 people, sells products in over 130 countries, and serves more than fifty million patients worldwide.
Average Trading Volume: 2,896,693
Technical Sentiment Signal: Buy
Current Market Cap: $16.22B
For an in-depth examination of COO stock, go to TipRanks’ Overview page.